“Without clinical research, Luis wouldn’t be here with us today.”
Leukaemia is one of the most common forms of childhood cancer. Nowadays, the chances of survival are good thanks to the findings of clinical trials conducted over the past decades. Nannette Keller talks about how her son Luis was cured thanks to major medical advances.
Childhood cancer research in Switzerland
Childhood cancer is one of the rare diseases. In Switzerland, it is almost exclusively non-profit academic organisations, such as universities and children’s hospitals, that conduct research in this area. Childhood cancer research requires sufficient financial resources for children and adolescents to continue to have access to cutting-edge cancer therapies. Since state funding is not sufficient, research has to be financed with donations and external funding.
Clinical research aims to explore therapies and treatments in humans to improve the chances of survival and reduce long-term consequences. The knowledge gained from clinical trials helps scientists to better understand the course of cancer diseases and to develop more modern therapy methods.
Epidemiological childhood cancer research in Switzerland evaluates data from the Swiss Childhood Cancer Registry, its own and international research projects. On the basis of such evaluations, statements can be made about the causes and development of different types of cancer as well as their progression and the effectiveness of therapies.
Basic research in oncology contributes to a better scientific understanding and thus to the fight against cancer. In the laboratory, studies are carried out on the changes that turn healthy cells into cancer cells, how they multiply, spread in the body and react to certain treatments.
What we do in the area of research
We fund various research projects in the field of paediatric oncology and also award an annual prize in the field of basic research to recognise innovative research projects in paediatric oncology. For the 2022 financial year, the total volume of funding contributions to paediatric cancer research amounts to around 267 694 Swiss francs. In addition, around 37 565 Swiss francs were allocated to the Fund for Basic Research to support projects.
Research projects we support:
Research Award 2022
Research project: Changes in the metabolism of paediatric tumour cells
Together with his team, basic researcher Raphael Morscher investigates changes in the metabolism of paediatric tumour cells. He hopes to develop new therapies that specifically target the metabolism of tumour cells and have as few long-term consequences as possible.
Research Award 2021
PhD research project: novel immunotherapy for the treatment of rhabdomyosarcoma (RMS)
This innovative research project of Andrea Timpanaro from the Bern University Hospital aims to develop a novel immunotherapy for rhabdomyosarcomas (RMS). RMS are among the most common malignant soft tissue tumours in children and adolescents.
Researcg Award 2020
Pilot study for optimising paediatric brain tumour therapy
Ana Guerreiro Stücklin at the University Children’s Hospital Zurich and her team are developing an innovative precision medicine platform for therapy optimisation for children with brain tumours, focusing on those with tumours refractory or resistant to standard therapies.
Award for childhood cancer research 2023
The 4th edition of the Childhood Cancer Research Prize has been launched
Childhood Cancer Switzerland honours research project
R. Morscher, MD, from the University Children’s Hospital Zurich awarded research
For parents of survivors with late effects
Invitation to the parents’ weekend in Schwarzenberg from 11 – 13 November 2022.
Award for Childhood Cancer Switzerland
Self-help project of the umbrella organisation receives CSS Foundation Award
Call for projects 2022: award for childhood cancer research
Childhood Cancer Switzerland awards a research prize of 25,000 Swiss francs.
Award for pioneering projects
Childhood Cancer Switzerland awards research prize to Andrea Timpanaro.
When a grandchild develops cancer
Study conducted on the needs and roles of grandparents.
Better therapies and chances of recovery
Childhood Cancer Switzerland supports key research projects.
Best possible therapies for malignant brain tumours
New trial for children and adolescents with high-risk medulloblastoma.